Prime Therapeutics clinical experts shared insights on the specialty drug pipeline at recent industry event

A look at the specialty landscape and how Prime delivers value to employers

Pat Gleason, assistant vice president, health outcomes, and David Eckwright, senior director, clinical project and program management, share an overview of Prime’s data and insights slated for this...

Cover image for Prime Therapeutics prioritizes patient-centered care, stays ahead of oncology trends Prime simplifies the cancer care pathway through innovative solutions that help manage complex...

Prime works to simplify medication management and support patients with migraine, making migraine treatment less of a pain point

Managed Markets Insight & Technology (MMIT)

Table view Editor-in-chief's message Year 2024 2025 2026 2027 2028 Projected Yearly U.S. Sales $0 $82 $177 $258 $311 The pipeline drug list is an aerial outline of drugs with anticipated FDA...

Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting.